Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Eccogene files for Hong Kong IPO, spotlights AZ deal on oral GLP-1 ECC5004 [7] [Hong Kong 23 Oct 2025] Context: AZ licensed ex-China rights to ECC5004 with $185M upfront and milestones
Even when the FDA approved newer, safer anti-obesity medications like Wegovy in 2021 and Zepbound in 2023, Medicare beneficiaries were locked out
Also, it can improve mood and sleep
Progressive proximal muscle weakness (affecting shoulders and hips more than hands and feet) may indicate an inflammatory myopathy or other serious neuromuscular condition that requires investigation beyond simply attributing symptoms to GLP-1 therapy
Goldman is amazing
& Bataller, R
US$ 27.65
US$ 22.83
US$ 23.11
US$ 25.42
US$ 23.08
